Table 2 Distribution of first medication used, by migraine sub-populations (n = 1,779)
From: GERD prevalence in migraine patients and the implication for acute migraine treatment
Medication type (%) | Diagnosed GERD n = 403 | Diagnosed heartburn n = 212 | Symptoms of GERD/heartburn n = 290 | No GERD or heartburn symptoms n = 927 | P value |
|---|---|---|---|---|---|
Triptans | 66.7 | 66.2 | 66.9 | 71.1 | |
NSAID and NSAID-containing | 3.1 | 4.8 | 4.6 | 5.6 | |
Prescription | 1.0 | 1.5 | 1.8 | 1.8 | |
OTC | 2.1 | 3.4 | 2.9 | 3.8 | |
Aspirin and aspirin-containing | 6.9 | 5.3 | 13.2a | 6.2 | <0.01 |
Prescription | 2.8 | 1.5 | 2.1 | 1.1 | |
OTC | 4.1 | 3.9 | 11.0 | 5.1 | |
Total NSAID and aspirin-containing medication | 10.0 | 10.1 | 17.8a | 11.8 | 0.001 |
Opioids | 6.2c | 7.7b | 2.1 | 4.4 | <0.01 |
Prescription (other) | 15.0c | 15.0b | 11.0 | 10.8 | <0.01 |
OTC (other) | 2.1 | 1.0 | 2.1 | 1.8 |